生物科技公司LB Pharmaceuticals纳斯达克上市：募资2.85亿美元

雷递网2025-09-14

雷递网雷建平 9月14日生物科技公司LB Pharmaceuticals(LBRX.US)日前在美国纳斯达克上市。LB Pharmaceuticals发行价为15美元，发行1900万股，募资总额为2.85亿美元。截至周六收盘，LB Pharmaceuticals股价为16.8美元，市值为3.38亿美元。自2025年2月Aardvark Therapeutics完成 9400万美元的IPO以来，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2567137482?lang=zh_CN&edition=full","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20250914/6389345027840030426558894.jpeg","is_english":false,"pubTime":"2025-09-14 12:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2567137482","market":"hk","top_or_hot":-1,"title":"生物科技公司LB Pharmaceuticals纳斯达克上市：募资2.85亿美元","media":"雷递网","content":"<div>\n<p>雷递网 雷建平 9月14日生物科技公司LB Pharmaceuticals(LBRX.US)日前在美国纳斯达克上市。LB Pharmaceuticals发行价为15美元，发行1900万股，募资总额为2.85亿美元。截至周六收盘，LB Pharmaceuticals股价为16.8美元，市值为3.38亿美元。自2025年2月Aardvark Therapeutics完成 9400万美元的IPO以来，...</p>\n\n<a href=\"https://www.leinews.com/n31195/detail.html\">网页链接</a>\n\n</div>\n","source":"leinews_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>生物科技公司LB Pharmaceuticals纳斯达克上市：募资2.85亿美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n生物科技公司LB Pharmaceuticals纳斯达克上市：募资2.85亿美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-09-14 12:38 北京时间&nbsp;&nbsp;&nbsp;<a href=https://www.leinews.com/n31195/detail.html><strong>雷递网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>雷递网 雷建平 9月14日生物科技公司LB Pharmaceuticals(LBRX.US)日前在美国纳斯达克上市。LB Pharmaceuticals发行价为15美元，发行1900万股，募资总额为2.85亿美元。截至周六收盘，LB Pharmaceuticals股价为16.8美元，市值为3.38亿美元。自2025年2月Aardvark Therapeutics完成 9400万美元的IPO以来，...</p>\n\n<a href=\"https://www.leinews.com/n31195/detail.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PSQ","symbol_name":"做空纳斯达克100指数ETF-ProShares","start_time":0,"source_url":"https://www.leinews.com/n31195/detail.html","article_id":"2567137482","we_media_id":null,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20250914/6389345027840030426558894.jpeg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2567137482","pubTimestamp":1757824701,"columns":[],"sourceInfo":{"source_id":"leinews_highlight","name":"雷帝触网"},"weMediaInfo":null,"summary":"生物科技公司LB Pharmaceuticals(LBRX.US)日前在美国纳斯达克上市，募资总额为2.85亿美元。截至周六收盘，LB Pharmaceuticals股价为16.8美元，市值为3.38亿美元。","collect":0,"end_time":0,"defaultTopTitle":"leinews.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"PSQ":"做空纳斯达克100指数ETF-ProShares","BK4233":"房地产运营公司","03086":"华夏纳指","NVIW.SI":"NVDA 3xLongSG261006","BK4007":"制药","ARTL":"Artelo Biosciences, Inc.","SQQQ":"纳指三倍做空ETF","LB":"LandBridge Co. LLC",".IXIC":"NASDAQ Composite","QLD":"2倍做多纳斯达克100指数ETF-ProShares","USJW.SI":"ALPHAB 3xLongSG261006","TSYW.SI":"TESLA 3xLongSG261006","TQQQ":"纳指三倍做多ETF","BK1147":"投资银行业与经纪业","QID":"两倍做空纳斯达克指数ETF-ProShares","BK4213":"石油与天然气的勘探与生产","USAW.SI":"AMZN 3xLongSG261006"},"translate_title":"Biotech company LB Pharmaceuticals listed on Nasdaq: raised $285 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LB":1,"QLD":0.6,"TQQQ":0.6,"NQmain":0.6,"ARTL":1,"MNQmain":0.6,"USAW.SI":0.6,".IXIC":1,"PSQ":0.6,"SQQQ":0.6,"NVIW.SI":0.6,"USJW.SI":0.6,"TSYW.SI":0.6,"QID":0.6,"03086":1},"content_text":"雷递网 雷建平 9月14日生物科技公司LB Pharmaceuticals(LBRX.US)日前在美国纳斯达克上市。LB Pharmaceuticals发行价为15美元，发行1900万股，募资总额为2.85亿美元。截至周六收盘，LB Pharmaceuticals股价为16.8美元，市值为3.38亿美元。自2025年2月Aardvark Therapeutics完成 9400万美元的IPO以来，没有一家公司能够通过上市获得巨额融资。LB Pharmaceuticals的上市意味着生物科技IPO走出寒冬，2025年生物科技IPO格局在复苏。无营收 上半年运营亏损1129万美元据介绍，LB Pharmaceuticals是一家临床阶段的生物制药公司，致力于开发用于治疗精神分裂症、双相抑郁症和其他神经精神疾病的新型疗法。LB Pharmaceuticals正在构建一条产品线，以利用候选产品LB-102的治疗潜力。公司称，LB-102有望成为美国首个获批用于治疗神经精神疾病的苯甲酰胺类抗精神病药物。LB-102一旦获批，将成精神科临床的支柱，为治疗精神分裂症、双相抑郁症和其他神经精神疾病提供一种潜在的品牌药和仿制药的替代方案。招股书显示，LB Pharmaceuticals暂无营收，2013年、2024年运营亏损分别为1138万美元、6483万美元；归属于普通股股东的净亏损分别为628万美元、6310万美元。LB Pharmaceuticals在2025年上半年运营亏损为1129万美元，上年同期的运营亏损为4321万美元；归属于普通股股东的净亏损为1018万美元，上年同期的归属于普通股股东的净亏损为4385万美元。股份被稀释严重LB Pharmaceuticals此次融资规模大，但估值不高，导致股东的股份被稀释很严重。IPO前，Deep Track Biotechnology Master Fund持股为19.9%，Vida Ventures持股为16%，Pontifax、TCG Crossover Fund II分别持股为12%，Zachary Prensky持股为2.6%。IPO后，Deep Track Biotechnology Master Fund持股3.1%，Vida Ventures持股2.5%，Pontifax、TCG Crossover Fund II分别持股1.8%。———————————————雷递由媒体人雷建平创办，若转载请写明来源。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2567137482","isCrawlerRequest":true}